NMR spectroscopy in drug development and analysis:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Weinheim
Wiley-VCH
©1999
|
| Schlagworte: | |
| Online-Zugang: | FRO01 UBG01 URL des Erstveröffentlichers |
| Beschreibung: | Includes bibliographical references and index Since the development of the NMR spectrometer in the 1950s, NMR spectra have been widely used for the elucidation of the 2D structure of newly synthesized and natural compounds. In the 1980s, the high-resolution NMR spectrometer (& 300 Mhz) and 2D experiments were introduced, which opens up the possibility to determine the 3D structure of large molecules, especially biomolecules. However, NMR spectroscopy has been rarely applied to drug analysis. This book illustrates the power and versatility of NMR spectroscopy in the determination of impurities in and the content of drugs, the composition o |
| Beschreibung: | 1 Online-Ressource (299 pages) |
| ISBN: | 9783527613656 352761365X 9783527613649 3527613641 3527300929 9783527300921 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043391933 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 160222s1999 |||| o||u| ||||||eng d | ||
| 020 | |a 9783527613656 |c electronic bk. |9 978-3-527-61365-6 | ||
| 020 | |a 352761365X |c electronic bk. |9 3-527-61365-X | ||
| 020 | |a 9783527613649 |9 978-3-527-61364-9 | ||
| 020 | |a 3527613641 |9 3-527-61364-1 | ||
| 020 | |a 3527300929 |9 3-527-30092-9 | ||
| 020 | |a 9783527300921 |9 978-3-527-30092-1 | ||
| 024 | 7 | |a 10.1002/9783527613649 |2 doi | |
| 035 | |a (ZDB-35-WIC)ocn649863884 | ||
| 035 | |a (OCoLC)649863884 | ||
| 035 | |a (DE-599)BVBBV043391933 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-861 | ||
| 082 | 0 | |a 615.19 |2 21 | |
| 100 | 1 | |a Holzgrabe, U. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a NMR spectroscopy in drug development and analysis |c U. Holzgrabe, I. Wawer, B. Diehl |
| 264 | 1 | |a Weinheim |b Wiley-VCH |c ©1999 | |
| 300 | |a 1 Online-Ressource (299 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a Since the development of the NMR spectrometer in the 1950s, NMR spectra have been widely used for the elucidation of the 2D structure of newly synthesized and natural compounds. In the 1980s, the high-resolution NMR spectrometer (& 300 Mhz) and 2D experiments were introduced, which opens up the possibility to determine the 3D structure of large molecules, especially biomolecules. However, NMR spectroscopy has been rarely applied to drug analysis. This book illustrates the power and versatility of NMR spectroscopy in the determination of impurities in and the content of drugs, the composition o | ||
| 650 | 4 | |a Chemistry, Pharmaceutical | |
| 650 | 4 | |a Drug Design | |
| 650 | 4 | |a Magnetic Resonance Spectroscopy | |
| 650 | 7 | |a MEDICAL / Drug Guides |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Pharmacy |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Nursing / Pharmacology |2 bisacsh | |
| 650 | 7 | |a Drug development |2 fast | |
| 650 | 7 | |a Drugs / Analysis |2 fast | |
| 650 | 7 | |a Nuclear magnetic resonance spectroscopy |2 fast | |
| 650 | 7 | |a Médicaments / Analyse |2 ram | |
| 650 | 7 | |a Résonance magnétique nucléaire |2 ram | |
| 650 | 7 | |a Spectroscopie de la résonance magnétique nucléaire |2 ram | |
| 650 | 7 | |a Pharmacie / Recherche |2 ram | |
| 650 | 7 | |a Arzneimittelanalyse |2 swd | |
| 650 | 7 | |a Arzneimittelentwicklung |2 swd | |
| 650 | 7 | |a NMR-Spektroskopie |2 swd | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Drug development | |
| 650 | 4 | |a Drugs / Analysis | |
| 650 | 4 | |a Nuclear magnetic resonance spectroscopy | |
| 650 | 0 | 7 | |a NMR-Spektroskopie |0 (DE-588)4075421-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelanalyse |0 (DE-588)4003116-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Arzneimittelanalyse |0 (DE-588)4003116-0 |D s |
| 689 | 0 | 1 | |a NMR-Spektroskopie |0 (DE-588)4075421-2 |D s |
| 689 | 0 | |8 1\p |5 DE-604 | |
| 689 | 1 | 0 | |a NMR-Spektroskopie |0 (DE-588)4075421-2 |D s |
| 689 | 1 | 1 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
| 689 | 1 | |8 2\p |5 DE-604 | |
| 700 | 1 | |a Wawer, I. |e Sonstige |4 oth | |
| 700 | 1 | |a Diehl, B. |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9783527613649 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-35-WIC | ||
| 940 | 1 | |q UBG_PDA_WIC | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028810517 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9783527613649 |l FRO01 |p ZDB-35-WIC |q FRO_PDA_WIC |x Verlag |3 Volltext | |
| 966 | e | |u https://onlinelibrary.wiley.com/doi/book/10.1002/9783527613649 |l UBG01 |p ZDB-35-WIC |q UBG_PDA_WIC |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175967803932672 |
|---|---|
| any_adam_object | |
| author | Holzgrabe, U. |
| author_facet | Holzgrabe, U. |
| author_role | aut |
| author_sort | Holzgrabe, U. |
| author_variant | u h uh |
| building | Verbundindex |
| bvnumber | BV043391933 |
| collection | ZDB-35-WIC |
| ctrlnum | (ZDB-35-WIC)ocn649863884 (OCoLC)649863884 (DE-599)BVBBV043391933 |
| dewey-full | 615.19 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.19 |
| dewey-search | 615.19 |
| dewey-sort | 3615.19 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03941nmm a2200841zc 4500</leader><controlfield tag="001">BV043391933</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">160222s1999 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783527613656</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-3-527-61365-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">352761365X</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">3-527-61365-X</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783527613649</subfield><subfield code="9">978-3-527-61364-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3527613641</subfield><subfield code="9">3-527-61364-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3527300929</subfield><subfield code="9">3-527-30092-9</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783527300921</subfield><subfield code="9">978-3-527-30092-1</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1002/9783527613649</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-35-WIC)ocn649863884</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)649863884</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043391933</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-861</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.19</subfield><subfield code="2">21</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Holzgrabe, U.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">NMR spectroscopy in drug development and analysis</subfield><subfield code="c">U. Holzgrabe, I. Wawer, B. Diehl</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Weinheim</subfield><subfield code="b">Wiley-VCH</subfield><subfield code="c">©1999</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (299 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Since the development of the NMR spectrometer in the 1950s, NMR spectra have been widely used for the elucidation of the 2D structure of newly synthesized and natural compounds. In the 1980s, the high-resolution NMR spectrometer (& 300 Mhz) and 2D experiments were introduced, which opens up the possibility to determine the 3D structure of large molecules, especially biomolecules. However, NMR spectroscopy has been rarely applied to drug analysis. This book illustrates the power and versatility of NMR spectroscopy in the determination of impurities in and the content of drugs, the composition o</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemistry, Pharmaceutical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Magnetic Resonance Spectroscopy</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Drug Guides</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacy</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Nursing / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drug development</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs / Analysis</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nuclear magnetic resonance spectroscopy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Médicaments / Analyse</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Résonance magnétique nucléaire</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Spectroscopie de la résonance magnétique nucléaire</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pharmacie / Recherche</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Arzneimittelanalyse</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">NMR-Spektroskopie</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug development</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs / Analysis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nuclear magnetic resonance spectroscopy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">NMR-Spektroskopie</subfield><subfield code="0">(DE-588)4075421-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelanalyse</subfield><subfield code="0">(DE-588)4003116-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimittelanalyse</subfield><subfield code="0">(DE-588)4003116-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">NMR-Spektroskopie</subfield><subfield code="0">(DE-588)4075421-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">NMR-Spektroskopie</subfield><subfield code="0">(DE-588)4075421-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wawer, I.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Diehl, B.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527613649</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-35-WIC</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">UBG_PDA_WIC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028810517</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527613649</subfield><subfield code="l">FRO01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">FRO_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://onlinelibrary.wiley.com/doi/book/10.1002/9783527613649</subfield><subfield code="l">UBG01</subfield><subfield code="p">ZDB-35-WIC</subfield><subfield code="q">UBG_PDA_WIC</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043391933 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:24:42Z |
| institution | BVB |
| isbn | 9783527613656 352761365X 9783527613649 3527613641 3527300929 9783527300921 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028810517 |
| oclc_num | 649863884 |
| open_access_boolean | |
| owner | DE-861 |
| owner_facet | DE-861 |
| physical | 1 Online-Ressource (299 pages) |
| psigel | ZDB-35-WIC UBG_PDA_WIC ZDB-35-WIC FRO_PDA_WIC ZDB-35-WIC UBG_PDA_WIC |
| publishDate | 1999 |
| publishDateSearch | 1999 |
| publishDateSort | 1999 |
| publisher | Wiley-VCH |
| record_format | marc |
| spelling | Holzgrabe, U. Verfasser aut NMR spectroscopy in drug development and analysis U. Holzgrabe, I. Wawer, B. Diehl Weinheim Wiley-VCH ©1999 1 Online-Ressource (299 pages) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index Since the development of the NMR spectrometer in the 1950s, NMR spectra have been widely used for the elucidation of the 2D structure of newly synthesized and natural compounds. In the 1980s, the high-resolution NMR spectrometer (& 300 Mhz) and 2D experiments were introduced, which opens up the possibility to determine the 3D structure of large molecules, especially biomolecules. However, NMR spectroscopy has been rarely applied to drug analysis. This book illustrates the power and versatility of NMR spectroscopy in the determination of impurities in and the content of drugs, the composition o Chemistry, Pharmaceutical Drug Design Magnetic Resonance Spectroscopy MEDICAL / Drug Guides bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh MEDICAL / Nursing / Pharmacology bisacsh Drug development fast Drugs / Analysis fast Nuclear magnetic resonance spectroscopy fast Médicaments / Analyse ram Résonance magnétique nucléaire ram Spectroscopie de la résonance magnétique nucléaire ram Pharmacie / Recherche ram Arzneimittelanalyse swd Arzneimittelentwicklung swd NMR-Spektroskopie swd Medizin Drug development Drugs / Analysis Nuclear magnetic resonance spectroscopy NMR-Spektroskopie (DE-588)4075421-2 gnd rswk-swf Arzneimittelanalyse (DE-588)4003116-0 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Arzneimittelanalyse (DE-588)4003116-0 s NMR-Spektroskopie (DE-588)4075421-2 s 1\p DE-604 Arzneimittelentwicklung (DE-588)4143176-5 s 2\p DE-604 Wawer, I. Sonstige oth Diehl, B. Sonstige oth https://onlinelibrary.wiley.com/doi/book/10.1002/9783527613649 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Holzgrabe, U. NMR spectroscopy in drug development and analysis Chemistry, Pharmaceutical Drug Design Magnetic Resonance Spectroscopy MEDICAL / Drug Guides bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh MEDICAL / Nursing / Pharmacology bisacsh Drug development fast Drugs / Analysis fast Nuclear magnetic resonance spectroscopy fast Médicaments / Analyse ram Résonance magnétique nucléaire ram Spectroscopie de la résonance magnétique nucléaire ram Pharmacie / Recherche ram Arzneimittelanalyse swd Arzneimittelentwicklung swd NMR-Spektroskopie swd Medizin Drug development Drugs / Analysis Nuclear magnetic resonance spectroscopy NMR-Spektroskopie (DE-588)4075421-2 gnd Arzneimittelanalyse (DE-588)4003116-0 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
| subject_GND | (DE-588)4075421-2 (DE-588)4003116-0 (DE-588)4143176-5 |
| title | NMR spectroscopy in drug development and analysis |
| title_auth | NMR spectroscopy in drug development and analysis |
| title_exact_search | NMR spectroscopy in drug development and analysis |
| title_full | NMR spectroscopy in drug development and analysis U. Holzgrabe, I. Wawer, B. Diehl |
| title_fullStr | NMR spectroscopy in drug development and analysis U. Holzgrabe, I. Wawer, B. Diehl |
| title_full_unstemmed | NMR spectroscopy in drug development and analysis U. Holzgrabe, I. Wawer, B. Diehl |
| title_short | NMR spectroscopy in drug development and analysis |
| title_sort | nmr spectroscopy in drug development and analysis |
| topic | Chemistry, Pharmaceutical Drug Design Magnetic Resonance Spectroscopy MEDICAL / Drug Guides bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh MEDICAL / Nursing / Pharmacology bisacsh Drug development fast Drugs / Analysis fast Nuclear magnetic resonance spectroscopy fast Médicaments / Analyse ram Résonance magnétique nucléaire ram Spectroscopie de la résonance magnétique nucléaire ram Pharmacie / Recherche ram Arzneimittelanalyse swd Arzneimittelentwicklung swd NMR-Spektroskopie swd Medizin Drug development Drugs / Analysis Nuclear magnetic resonance spectroscopy NMR-Spektroskopie (DE-588)4075421-2 gnd Arzneimittelanalyse (DE-588)4003116-0 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
| topic_facet | Chemistry, Pharmaceutical Drug Design Magnetic Resonance Spectroscopy MEDICAL / Drug Guides MEDICAL / Pharmacology MEDICAL / Pharmacy MEDICAL / Nursing / Pharmacology Drug development Drugs / Analysis Nuclear magnetic resonance spectroscopy Médicaments / Analyse Résonance magnétique nucléaire Spectroscopie de la résonance magnétique nucléaire Pharmacie / Recherche Arzneimittelanalyse Arzneimittelentwicklung NMR-Spektroskopie Medizin |
| url | https://onlinelibrary.wiley.com/doi/book/10.1002/9783527613649 |
| work_keys_str_mv | AT holzgrabeu nmrspectroscopyindrugdevelopmentandanalysis AT waweri nmrspectroscopyindrugdevelopmentandanalysis AT diehlb nmrspectroscopyindrugdevelopmentandanalysis |